Fig. 2: The chimeric antigen receptor (CAR) T cell treatment process for multiple myeloma and the structure of CAR-T cell.
From: Targeted immunotherapy: harnessing the immune system to battle multiple myeloma
FC fludarabine and cyclophosphamide.
Fig. 2: The chimeric antigen receptor (CAR) T cell treatment process for multiple myeloma and the structure of CAR-T cell. | Cell Death Discovery
